KEARSTON TAYLOR: Open Payments
NPI 1285368357 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,338 in 68 payments from 16 companies in 2025. Trend: 2023 $1,304 · 2024 $1,877 · 2025 $1,338
Food & beverage: $1,338
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $224 |
| Regeneron Healthcare Solutions, Inc. | 9 | $196 |
| GlaxoSmithKline, LLC. | 18 | $190 |
| AstraZeneca Pharmaceuticals LP | 9 | $168 |
| Inspire Medical Systems, Inc. | 2 | $90 |
| Lilly USA, LLC | 1 | $90 |
| Grifols USA, LLC | 3 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Mallinckrodt Hospital Products Inc. | 2 | $57 |
| Insmed, Inc. | 2 | $45 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, INSPIRE, ZEPBOUND, TRELEGY ELLIPTA, Prolastin-C Liquid, OFEV.
Industry payments across OH — which companies pay providers there.
